• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从高级别浆液性卵巢癌中建立的 7 个新细胞系的分子特征。

Molecular characterization of 7 new established cell lines from high grade serous ovarian cancer.

机构信息

Molecular Oncology Group, Department of Obstetrics and Gynecology, Comprehensive Cancer Center, Medical University of Vienna, Waehringer Guertel 18-20, 5Q, A-1090 Vienna, Austria.

Center for Medical Statistics, Informatics and Intelligent Systems, Medical University of Vienna, Vienna, Austria.

出版信息

Cancer Lett. 2015 Jul 1;362(2):218-28. doi: 10.1016/j.canlet.2015.03.040. Epub 2015 Apr 8.

DOI:10.1016/j.canlet.2015.03.040
PMID:25862976
Abstract

Cancer cell lines are good in vitro models to study molecular mechanisms underlying chemoresistance and cancer recurrence. Recent works have demonstrated that most of the available ovarian cancer cell lines are most unlikely high grade serous (HGSOC), the major type of epithelial ovarian cancer. We aimed at establishing well characterized HGSOC cell lines, which can be used as optimal models for ovarian cancer research. We successfully established seven cell lines from HGSOC and provided the major genomic alterations and the transcriptomic landscapes of them. They exhibited different gene expression patterns in the key pathways involved in cancer resistance. Each cell line harbored a unique TP53 mutation as their corresponding tumors and expressed cytokeratins 8/18/19 and EpCAM. Two matched lines were established from the same patient, one at diagnosis and being sensitive to carboplatin and the other during chemotherapy and being resistant. Two cell lines presented respective BRCA1 and BRCA2 mutations. To conclude, we have established seven cell lines and well characterized them at genomic and transcriptomic levels. They are optimal models to investigate the molecular mechanisms underlying the progression, chemo resistance and recurrence of HGSOC.

摘要

癌细胞系是研究化学抗性和癌症复发的分子机制的良好体外模型。最近的研究表明,大多数现有的卵巢癌细胞系极不可能是高级别浆液性卵巢癌(HGSOC),HGSOC 是上皮性卵巢癌的主要类型。我们旨在建立特征良好的 HGSOC 细胞系,这些细胞系可作为卵巢癌研究的最佳模型。我们成功地从 HGSOC 中建立了七个细胞系,并提供了它们的主要基因组改变和转录组景观。它们在涉及癌症抗性的关键途径中表现出不同的基因表达模式。每个细胞系都携带与其相应肿瘤相同的 TP53 突变,并表达细胞角蛋白 8/18/19 和 EpCAM。从同一位患者建立了两个匹配的细胞系,一个在诊断时对卡铂敏感,另一个在化疗期间耐药。两个细胞系分别呈现各自的 BRCA1 和 BRCA2 突变。总之,我们已经建立了七个细胞系,并在基因组和转录组水平上对它们进行了很好的表征。它们是研究 HGSOC 进展、化疗耐药和复发的分子机制的最佳模型。

相似文献

1
Molecular characterization of 7 new established cell lines from high grade serous ovarian cancer.从高级别浆液性卵巢癌中建立的 7 个新细胞系的分子特征。
Cancer Lett. 2015 Jul 1;362(2):218-28. doi: 10.1016/j.canlet.2015.03.040. Epub 2015 Apr 8.
2
[Clinical significance and distribution of BRCA genes mutation in sporadic high grade serous ovarian cancer].[散发性高级别浆液性卵巢癌中BRCA基因突变的临床意义及分布]
Zhonghua Fu Chan Ke Za Zhi. 2017 Jan 25;52(1):26-31. doi: 10.3760/cma.j.issn.0529-567X.2017.01.007.
3
Establishment and Characterization of the Novel High-Grade Serous Ovarian Cancer Cell Line OVPA8.新型高级别浆液性卵巢癌细胞系 OVPA8 的建立与鉴定。
Int J Mol Sci. 2018 Jul 17;19(7):2080. doi: 10.3390/ijms19072080.
4
BRCA mutational status, initial disease presentation, and clinical outcome in high-grade serous advanced ovarian cancer: a multicenter study.高级别浆液性晚期卵巢癌的BRCA突变状态、初始疾病表现及临床结局:一项多中心研究
Am J Obstet Gynecol. 2017 Sep;217(3):334.e1-334.e9. doi: 10.1016/j.ajog.2017.05.036. Epub 2017 May 23.
5
BRCA1 and BRCA2 mutations correlate with TP53 abnormalities and presence of immune cell infiltrates in ovarian high-grade serous carcinoma.BRCA1 和 BRCA2 突变与卵巢高级别浆液性癌中的 TP53 异常和免疫细胞浸润的存在相关。
Mod Pathol. 2012 May;25(5):740-50. doi: 10.1038/modpathol.2011.211. Epub 2012 Jan 27.
6
Germline BRCA1 and BRCA2 mutations in ovarian cancer: utility of a histology-based referral strategy.基于组织学的转诊策略在卵巢癌中胚系 BRCA1 和 BRCA2 突变的应用。
Obstet Gynecol. 2012 Aug;120(2 Pt 1):235-40. doi: 10.1097/AOG.0b013e31825f3576.
7
Tumor genomic, transcriptomic, and immune profiling characterizes differential response to first-line platinum chemotherapy in high grade serous ovarian cancer.肿瘤基因组、转录组和免疫特征分析揭示高级别浆液性卵巢癌一线铂类化疗反应的差异。
Cancer Med. 2021 May;10(9):3045-3058. doi: 10.1002/cam4.3831. Epub 2021 Apr 3.
8
Patient-derived cell line models revealed therapeutic targets and molecular mechanisms underlying disease progression of high grade serous ovarian cancer.患者来源的细胞系模型揭示了高级别浆液性卵巢癌疾病进展的治疗靶点和分子机制。
Cancer Lett. 2019 Sep 10;459:1-12. doi: 10.1016/j.canlet.2019.05.032. Epub 2019 May 28.
9
An immune-centric exploration of BRCA1 and BRCA2 germline mutation related breast and ovarian cancers.从免疫角度探索 BRCA1 和 BRCA2 种系突变相关的乳腺癌和卵巢癌。
BMC Cancer. 2020 Mar 12;20(1):197. doi: 10.1186/s12885-020-6605-1.
10
Is low-grade serous ovarian cancer part of the tumor spectrum of hereditary breast and ovarian cancer?低级别浆液性卵巢癌是否属于遗传性乳腺癌和卵巢癌肿瘤谱的一部分?
Gynecol Oncol. 2011 Feb;120(2):229-32. doi: 10.1016/j.ygyno.2010.10.033. Epub 2010 Dec 3.

引用本文的文献

1
Creation and Validation of Patient-Derived Cancer Model Using Peritoneal and Pleural Effusion in Patients with Advanced Ovarian Cancer: An Early Experience.利用晚期卵巢癌患者的腹水和胸水建立及验证患者来源的癌症模型:早期经验
J Clin Med. 2024 May 6;13(9):2718. doi: 10.3390/jcm13092718.
2
Comparison of the Cost and Effect of Combined Conditioned Medium and Conventional Medium for Fallopian Tube Organoid Cultures.比较联合条件培养基和常规培养基用于输卵管类器官培养的成本和效果。
Cell Transplant. 2023 Jan-Dec;32:9636897231160216. doi: 10.1177/09636897231160216.
3
Harnessing preclinical models for the interrogation of ovarian cancer.
利用临床前模型探究卵巢癌。
J Exp Clin Cancer Res. 2022 Sep 16;41(1):277. doi: 10.1186/s13046-022-02486-z.
4
The organoid: A research model for ovarian cancer.类器官:一种卵巢癌研究模型。
Tzu Chi Med J. 2021 Jul 9;34(3):255-260. doi: 10.4103/tcmj.tcmj_63_21. eCollection 2022 Jul-Sep.
5
Metabolism of Estrogens: Turnover Differs Between Platinum-Sensitive and -Resistant High-Grade Serous Ovarian Cancer Cells.雌激素的代谢:铂敏感和铂耐药的高级别浆液性卵巢癌细胞之间的周转率存在差异。
Cancers (Basel). 2020 Jan 23;12(2):279. doi: 10.3390/cancers12020279.
6
TIMP-1 is Overexpressed and Secreted by Platinum Resistant Epithelial Ovarian Cancer Cells.TIMP-1 由铂耐药上皮性卵巢癌细胞过度表达和分泌。
Cells. 2019 Dec 18;9(1):6. doi: 10.3390/cells9010006.
7
Oncolytic virus immunotherapies in ovarian cancer: moving beyond adenoviruses.卵巢癌中的溶瘤病毒免疫疗法:超越腺病毒
Porto Biomed J. 2018 Jun 29;3(1):e7. doi: 10.1016/j.pbj.0000000000000007. eCollection 2018 Aug.
8
Artemisinin induced reversal of EMT affects the molecular biological activity of ovarian cancer SKOV3 cell lines.青蒿素诱导的上皮-间质转化逆转影响卵巢癌SKOV3细胞系的分子生物学活性。
Oncol Lett. 2019 Sep;18(3):3407-3414. doi: 10.3892/ol.2019.10608. Epub 2019 Jul 11.
9
USP1 links platinum resistance to cancer cell dissemination by regulating Snail stability.USP1 通过调控 Snail 的稳定性将铂类耐药与癌细胞扩散联系起来。
Sci Adv. 2019 May 8;5(5):eaav3235. doi: 10.1126/sciadv.aav3235. eCollection 2019 May.
10
An Interactive Resource to Probe Genetic Diversity and Estimated Ancestry in Cancer Cell Lines.癌症细胞系遗传多样性和祖源分析的交互式资源
Cancer Res. 2019 Apr 1;79(7):1263-1273. doi: 10.1158/0008-5472.CAN-18-2747. Epub 2019 Mar 20.